gentamicin has been researched along with norfloxacin in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (36.17) | 18.7374 |
| 1990's | 10 (21.28) | 18.2507 |
| 2000's | 6 (12.77) | 29.6817 |
| 2010's | 7 (14.89) | 24.3611 |
| 2020's | 7 (14.89) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnin, C; Bron, AM; Garcher, C; Lallemand, A | 1 |
| Fukuda, H; Hashimoto, H; Hirai, K; Iyobe, S; Jakics, EB | 1 |
| Cook, TJ; Miller, IM; Vogel, R; Wittreich, J | 1 |
| Arocker-Mettinger, E; Baumgartner, I; Georgiew, L; Grabner, G; Huber-Spitzy, V; Schiffbänker, M | 1 |
| Baer, JC; Bauer, SA; Glaros, DS; Nirankari, VS | 1 |
| Clarke, AM; Zemcov, SJ | 2 |
| Badanjak, A; Bogdanic, V; Davila, N; Francetić, I; Kalenic, S; Labar, B; Nemet, D | 1 |
| Hannan, PC; O'Hanlon, PJ; Rogers, NH | 1 |
| Edlund, C; Lahnborg, G; Nord, CE | 1 |
| Bertram, MA; Kelley, SG; Young, LS | 1 |
| Bailer, R; Chu, DT; Fernandes, PB; Hanson, CW; Stamm, JM; Vojtko, C | 1 |
| DiVincenzo, CA; O'Keefe, JP; Tatarowicz, W; Venezio, FR | 1 |
| Baars, B; Cullmann, W; Opferkuch, W; Stieglitz, M | 1 |
| Campbell, ME; Clarke, AM; Zemcov, SJ | 1 |
| Berlioux, J; Daguet, GL; Mugnier, P; Pasteau, C; Ygout, JF | 1 |
| Caccamo, F; Nicoletti, G; Nicolosi, VM; Speciale, A; Stefani, S | 1 |
| DiVincenzo, C; Foster, JK; Lentino, JR; Strodtman, R | 1 |
| Drusano, GL; Morris, JG; Tenney, JH | 1 |
| Kashimoto, S; Katae, H; Minami, A; Nakamura, S; Nakata, K; Shimizu, M; Takase, Y; Yamagishi, J | 1 |
| Forward, KR; Gray, GJ; Harding, GK; Ronald, AR; Urias, BA | 1 |
| Abruzzo, GK; Fromtling, RA; Gadebusch, HH | 1 |
| Seiga, K; Shoji, T | 1 |
| Arneborn, P; Blad, L; Sjöberg, L; Sundman, K; Vikerfors, T | 1 |
| Gallés, C; Gasós, MA; Sauca, G | 1 |
| Badrinath, S; Rao, RS; Vijayalakshmi, N | 1 |
| Caron, F | 1 |
| Amaro Martins, VC; Goissis, G | 1 |
| Burke, TJ; Campbell, KL; Kakoma, I; Kim, CH; Koo, HY; McKiernan, BC; Oluoch, AO; Siegel, AM; Weisiger, RM | 1 |
| Araj, GF; Zouain, MG | 1 |
| Janicka, G; Kłyszejko, C; Sekowska, A; Szymankiewicz, M; Wojda, M; Wróblewski, M | 1 |
| Gerkowicz, M; Gruszecka-Gerkowicz, R; Kosior-Jarecka, E; Pietraś-Trzpiel, M | 1 |
| Ram, S; Seth, PK; Shanker, R; Singh, RL; Tripathi, U; Vajpayee, P | 1 |
| Callura, JM; Camacho, DM; Collins, JJ; Dwyer, DJ; Kohanski, MA | 1 |
| Matar, GM; Nassar, FJ; Rahal, EA; Sabra, A | 1 |
| Azad, CS; Bhunia, SS; Krishna, A; Saxena, AK; Shukla, PK | 1 |
| Akutagawa, M; Emoto, T; Harada, Y; Hou, Y; Kinouchi, Y; Mawatari, K; Nakahashi, M; Shimohata, T; Takahashi, A; Tsunedomi, A; Uebanso, T | 1 |
| Andrade, TA; Araújo, AAS; Costa, MDS; Coutinho, HDM; Cruz, RPD; Freitas, TS; Menezes, IRA; Menezes, PDP; Nunes, PS; Oliveira, FS; Pereira, RLS; Quintans-Júnior, LJ; Serafini, MR; Sousa, BMH | 1 |
| Andrade, GI; Belo, NO; Carvalho, IA; Costa, EA; Costa, FN; Pereira, LS; Santos, RL | 1 |
| Gonçalves de Souza, T; Karine de Sousa, A; Melo Coutinho, HD; Ribeiro-Filho, J; Rocha, JE; Sampaio de Freitas, T | 1 |
| Al-Maary, KS; Alwarhi, WK; El-Hariri, MD; Eljakee, JK; Ghareeb, A; Hemeg, HA; Hussein, HA; Kabli, SA; Magdy, OS; Moussa, IM; Mubarak, AS | 1 |
| Albuquerque da Silva, AC; Amaral, WD; Barbosa-Filho, JM; Confortin, C; Datiane de Morais Oliveira-Tintino, C; Deschamps, C; Everson da Silva, L; Freitas, PR; Justino de Araújo, AC; Melo Coutinho, HD; Muniz, DF; Ramos de Lima, NT; Ribeiro-Filho, J; Rocha, JE; Rodrigues Dos Santos Barbosa, C; Tintino, SR | 1 |
| Altaeb, AA; Bennour, EM; Duro, EM; Ellraiss, OM; Elmishri, RA; Hiblu, MA; Karim, ES | 1 |
| Alzahrani, KJ; Anafo, RB; Atiase, Y; Dayie, NTKD; Donkor, ES; Duodu, S; Kotey, FCN; Osei, MM; Tetteh-Quarcoo, PB | 1 |
| de Souza Santos, LV; Jacob, RS; Lange, LC; Lebron, YAR; Martins, DCDS; Moreira, VR | 1 |
| Araújo, NJS; Coutinho, HDM; da Silva, ARP; de Freitas, TS; de Sousa, EO; de Vasconcelos, JEL; do Socorro Costa, M; Filho, JMB; Maia, FPA; Pereira Junior, FN; Pinheiro, JCA; Tavares, JF | 1 |
| Adhikary, A; Biswal, S; Chatterjee, D; Ghosh, AS | 1 |
1 review(s) available for gentamicin and norfloxacin
| Article | Year |
|---|---|
[Current role of aminoglycosides in the treatment of acute pyelonephritis].
Topics: Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefadroxil; Cefotaxime; Cephalosporins; Ciprofloxacin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gentamicins; Humans; Infusions, Intravenous; Inpatients; Male; Norfloxacin; Pyelonephritis; Recurrence; Time Factors; Tobramycin; Urinary Tract Infections | 1998 |
4 trial(s) available for gentamicin and norfloxacin
| Article | Year |
|---|---|
Topically administered norfloxacin compared with topically administered gentamicin for the treatment of external ocular bacterial infections. The Worldwide Norfloxacin Ophthalmic Study Group.
Topics: Administration, Topical; Adolescent; Adult; Aged; Bacterial Infections; Blepharitis; Conjunctivitis; Double-Blind Method; Eye Infections, Bacterial; Gentamicins; Humans; Middle Aged; Norfloxacin; Treatment Outcome | 1992 |
Prevention of gram-negative bacterial infection in granulocytopenic patients: a randomized study comparing oral norfloxacin with gentamycin.
Topics: Administration, Oral; Adolescent; Adult; Agranulocytosis; Bacterial Infections; Gentamicins; Gram-Negative Bacteria; Humans; Leukemia; Middle Aged; Norfloxacin; Randomized Controlled Trials as Topic | 1989 |
One bolus dose of gentamicin and early oral therapy versus cefotaxime and subsequent oral therapy in the treatment of febrile urinary tract infection.
Topics: Adult; Aged; Aged, 80 and over; Cefotaxime; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Middle Aged; Norfloxacin; Prospective Studies; Urinary Tract Infections | 1997 |
[Changes in bacterial flora of conjunctival sac in patients prophylacticaly treated with antibiotic before cataract operation].
Topics: Antibiotic Prophylaxis; Cataract; Cataract Extraction; Chloramphenicol; Conjunctiva; Conjunctivitis, Bacterial; Female; Gentamicins; Humans; Male; Norfloxacin; Ofloxacin | 2005 |
42 other study(ies) available for gentamicin and norfloxacin
| Article | Year |
|---|---|
Gentamicin, norfloxacin and lysozyme concentration in human tears: in vivo and in vitro study.
Topics: Adolescent; Adult; Cornea; Gentamicins; Humans; In Vitro Techniques; Male; Muramidase; Norfloxacin; Ophthalmic Solutions; Tears | 1992 |
Occurrence of the nfxB type mutation in clinical isolates of Pseudomonas aeruginosa.
Topics: Carbenicillin; Chloramphenicol; Drug Resistance, Microbial; Genes, Bacterial; Gentamicins; Imipenem; Microbial Sensitivity Tests; Mutation; Norfloxacin; Phenotype; Plasmids; Pseudomonas aeruginosa; Transformation, Bacterial | 1992 |
[Corneal ulcer. Current analysis from specialized ambulatory care of a clinic].
Topics: Ambulatory Care; Anti-Bacterial Agents; Bacterial Infections; Contact Lenses, Extended-Wear; Corneal Ulcer; Cortisone; Drug Therapy, Combination; Gentamicins; Humans; Microbial Sensitivity Tests; Norfloxacin; Ophthalmic Solutions; Prospective Studies; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections | 1992 |
Streptococcus sanguis survival in K-Sol. Comparison of gentamicin and the fluoroquinolone antibiotics.
Topics: Anti-Infective Agents; Chondroitin Sulfates; Ciprofloxacin; Colony Count, Microbial; Gentamicins; HEPES; Norfloxacin; Ofloxacin; Streptococcus sanguis | 1991 |
Comparative in vitro activity of lomefloxacin, a new difluoroquinolone.
Topics: Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Ceftazidime; Ciprofloxacin; Drug Evaluation, Preclinical; Fluoroquinolones; Gentamicins; Microbial Sensitivity Tests; Norfloxacin; Quinolones | 1989 |
In vitro evaluation of various quinolone antibacterial agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bordetella; Diterpenes; Gentamicins; Haemophilus; Microbial Sensitivity Tests; Mycoplasma; Norfloxacin; Pasteurella; Respiratory Tract Infections; Swine; Swine Diseases; Time Factors | 1989 |
The efficacy of pefloxacin in comparison to gentamicin in the treatment of experimentally induced peritonitis in rats.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Clostridium perfringens; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Gentamicins; Klebsiella pneumoniae; Male; Metronidazole; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Peritonitis; Proteus mirabilis; Rats; Rats, Inbred Strains | 1986 |
Activity of ciprofloxacin against resistant clinical isolates.
Topics: Bacteria; Bacterial Infections; Cefotaxime; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Humans; Microbial Sensitivity Tests; Norfloxacin; Quinolines | 1986 |
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Topics: Anti-Infective Agents; Aztreonam; Bacteria; Cefotaxime; Ciprofloxacin; Drug Combinations; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Gentamicins; Haemophilus influenzae; Half-Life; Humans; Imipenem; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Penicillins; Piperacillin; Piperazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Streptococcus; Thienamycins | 1986 |
Activity of ciprofloxacin against multiply resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, and group JK corynebacteria.
Topics: Actinomycetales; Cefotaxime; Ciprofloxacin; Gentamicins; Humans; Methicillin; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillin Resistance; Pseudomonas aeruginosa; Staphylococcus epidermidis; Ticarcillin; Vancomycin | 1986 |
In vitro activity of the new 4-quinolone compound Ro 23-6240.
Topics: Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Fleroxacin; Gentamicins; Haemophilus influenzae; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1987 |
Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
Topics: Acinetobacter; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Haemophilus influenzae; Mezlocillin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus | 1985 |
In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Enoxacin; Gentamicins; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin | 1985 |
[Phenotypes of resistance to antibiotics of Acinetobacter baumannii. Impact on therapeutic orientation].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Norfloxacin; Pefloxacin; Phenotype; Thienamycins | 1988 |
The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
Topics: Ampicillin; Anti-Bacterial Agents; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Piperacillin | 1987 |
Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Gentamicins; Kinetics; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Penicillin Resistance; Staphylococcus aureus; Vancomycin | 1986 |
In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents.
Topics: Ampicillin; Chloramphenicol; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Tetracycline; Trimethoprim; Vibrio | 1985 |
Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in mice.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Enoxacin; Gentamicins; Male; Mice; Nalidixic Acid; Naphthyridines; Norfloxacin; Pipemidic Acid | 1983 |
Comparative activities of norfloxacin and fifteen other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa strains.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pseudomonas aeruginosa | 1983 |
Antibacterial efficacy of norfloxacin, trimethoprim-sulfamethoxazole, and gentamicin in experimentally-infected normal and streptozotocin-induced diabetic mice.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Diabetes Mellitus, Experimental; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Female; Gentamicins; Mice; Nalidixic Acid; Norfloxacin; Sulfamethizole; Sulfathiazoles; Trimethoprim | 1984 |
[Chemoprophylaxis of ophthalmia neonatorum through vertical infection. Evaluation of Crede's method using norfloxacin and gentamicin].
Topics: Adult; Female; Gentamicins; Humans; Infant, Newborn; Norfloxacin; Ophthalmia Neonatorum; Pregnancy | 1993 |
[Changes in the sensitivity of Escherichia coli to 6 antimicrobial agents during the last 12 years. Group of Microbiologists of County Hospitals of Catalonia].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Spain; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
Minimum inhibitory concentration (MIC) of some antibiotics against Vibrio cholerae O139 isolates from Pondicherry.
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Furazolidone; Gentamicins; India; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; O Antigens; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio cholerae | 1997 |
Nonstoichiometric hydroxyapatite-anionic collagen composite as support for the double sustained release of gentamicin and norfloxacin/ciprofloxacin.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Biocompatible Materials; Biodegradation, Environmental; Bone Diseases; Calcium; Chelating Agents; Ciprofloxacin; Collagen; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Delivery Systems; Durapatite; Gentamicins; Gram-Negative Bacteria; Male; Norfloxacin; Osteogenesis; Rats | 2000 |
Nonenteric Escherichia coli isolates from dogs: 674 cases (1990-1998).
Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dog Diseases; Dogs; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Gentamicins; Infections; Male; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Respiratory System; Retrospective Studies; Skin; Urine | 2001 |
Antimicrobial resistance of Enterococci in Lebanon.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Erythromycin; Gentamicins; Humans; Lebanon; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Rifampin; Streptomycin; Teicoplanin; Tetracycline; Vancomycin | 2001 |
Resistance of Klebsiella pneumoniae strains producing and not producing ESBL (extended-spectrum beta-lactamase) type enzymes to selected non-beta-lactam antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Microbial; Gentamicins; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nalidixic Acid; Netilmicin; Norfloxacin; Prevalence; Time Factors | 2002 |
Determination of antimicrobial resistance and virulence gene signatures in surface water isolates of Escherichia coli.
Topics: Anti-Bacterial Agents; Cefotaxime; Drug Resistance, Multiple, Bacterial; Enterotoxigenic Escherichia coli; Gentamicins; India; Microbial Sensitivity Tests; Norfloxacin; Polymerase Chain Reaction; Rivers; Shiga-Toxigenic Escherichia coli; Virulence Factors; Water Microbiology | 2008 |
Antibiotic-induced bacterial cell death exhibits physiological and biochemical hallmarks of apoptosis.
Topics: Ampicillin; Anti-Bacterial Agents; Apoptosis; Bacterial Proteins; Caspases; Chromosomes, Bacterial; DNA Fragmentation; Endopeptidase Clp; Escherichia coli; Escherichia coli Proteins; Gentamicins; In Situ Nick-End Labeling; Norfloxacin; Phosphatidylserines; Rec A Recombinases; SOS Response, Genetics; Stress, Physiological; Substrate Specificity | 2012 |
Effects of subinhibitory concentrations of antimicrobial agents on Escherichia coli O157:H7 Shiga toxin release and role of the SOS response.
Topics: Anti-Infective Agents; Azithromycin; DNA, Bacterial; Escherichia coli O157; Gene Expression Regulation, Bacterial; Genes, Bacterial; Gentamicins; Humans; Imipenem; Latex Fixation Tests; Microbial Sensitivity Tests; Norfloxacin; Prophages; Real-Time Polymerase Chain Reaction; Rifampin; Shiga Toxin; SOS Response, Genetics | 2013 |
Novel Glycoconjugate of 8-Fluoro Norfloxacin Derivatives as Gentamicin-resistant Staphylococcus aureus Inhibitors: Synthesis and Molecular Modelling Studies.
Topics: Drug Resistance, Bacterial; Gentamicins; Glycoconjugates; Models, Molecular; Norfloxacin; Staphylococcal Infections; Staphylococcus aureus | 2015 |
Combined treatment of UVA irradiation and antibiotics induces greater bactericidal effects on Vibrio parahaemolyticus.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Disinfection; Gentamicins; Humans; Norfloxacin; Ultraviolet Rays; Vibrio parahaemolyticus | 2016 |
Evaluation of the antibacterial and modulatory potential of α-bisabolol, β-cyclodextrin and α-bisabolol/β-cyclodextrin complex.
Topics: alpha-Cyclodextrins; Anti-Bacterial Agents; beta-Cyclodextrins; Drug Compounding; Drug Resistance, Multiple, Bacterial; Drug Synergism; Escherichia coli; Gentamicins; Microbial Sensitivity Tests; Monocyclic Sesquiterpenes; Norfloxacin; Pseudomonas aeruginosa; Sesquiterpenes; Staphylococcus aureus | 2017 |
Frequency of enterotoxins, toxic shock syndrome toxin-1, and biofilm formation genes in Staphylococcus aureus isolates from cows with mastitis in the Northeast of Brazil.
Topics: Amoxicillin; Animals; Bacterial Toxins; Biofilms; Brazil; Cattle; Enterotoxins; Female; Gentamicins; Mastitis, Bovine; Norfloxacin; Staphylococcal Infections; Staphylococcus aureus; Superantigens; Virulence; Virulence Factors | 2018 |
New roles of fluoxetine in pharmacology: Antibacterial effect and modulation of antibiotic activity.
Topics: Anti-Bacterial Agents; Antidepressive Agents; Bacteria; Drug Combinations; Drug Synergism; Erythromycin; Escherichia coli; Fluoxetine; Gentamicins; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Tetracycline | 2018 |
Genetic diversity of Salmonella enterica recovered from chickens farms and its potential transmission to human.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Chickens; Colistin; Fluoroquinolones; Genetic Variation; Gentamicins; Humans; Nalidixic Acid; Norfloxacin; Penicillins; Phylogeny; Polymerase Chain Reaction; Poultry Diseases; Salmonella enterica; Salmonella Infections, Animal; Sequence Alignment; Sequence Analysis, DNA; Zoonoses | 2020 |
GC-MS-FID characterization and antibacterial activity of the Mikania cordifolia essential oil and limonene against MDR strains.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Escherichia coli; Gas Chromatography-Mass Spectrometry; Gentamicins; Limonene; Microbial Sensitivity Tests; Mikania; Norfloxacin; Oils, Volatile; Plant Oils; Pseudomonas aeruginosa; Staphylococcus aureus | 2020 |
Otodectic and bacterial etiology of feline otitis externa in Tripoli, Libya.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Female; Gentamicins; Libya; Male; Mite Infestations; Mites; Norfloxacin; Otitis Externa; Prevalence; Proteus; Proteus Infections; Pseudomonas; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus | 2021 |
Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage among patients with diabetes at the Korle Bu Teaching Hospital.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Carrier State; Clindamycin; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Nasal Cavity; Norfloxacin; Penicillins; Rifampin; Staphylococcal Infections; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |
Norfloxacin and gentamicin degradation catalyzed by manganese porphyrins under mild conditions: the importance of toxicity assessment.
Topics: Catalysis; Gentamicins; Manganese; Norfloxacin; Oxidation-Reduction; Porphyrins | 2022 |
Evaluation of the antibacterial and inhibitory activity of NorA and MepA efflux pumps from Staphylococcus aureus by diosgenin.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Diosgenin; Escherichia coli; Ethidium; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Norfloxacin; Saponins; Staphylococcal Infections; Staphylococcus aureus | 2022 |
A NiCoT family metal transporter of
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cobalt; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Ethambutol; Gentamicins; Isoleucine; Isoniazid; Kanamycin; Leucine; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nalidixic Acid; Neomycin; Nickel; Norfloxacin; Ofloxacin | 2022 |